Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer
January 07, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Krishna R. Polu, M.D., as its Chief Medical Officer and Michael P. Smith...
Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors
December 18, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors,...
Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 01, 2014 09:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on November 25, 2014, as a key requirement of the Company's strategy of strengthening...
Raptor Pharmaceutical to Present at the 26th Annual Piper Jaffray Healthcare Conference
November 18, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will participate in the following conference:
Julie Anne Smith,...
Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update
November 06, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Global Net Product Sales for PROCYSBI® of $23.8 Million for Third Quarter 2014
PROCYSBI Revenue of $52.2 Million Reached Through September
2014 PROCYSBI Revenue Guidance of $65-$70 Million...
Raptor Pharmaceutical to Hold Third Quarter 2014 Financial Results Conference Call and Webcast on Thursday, November 6, at 4:30 p.m. ET
October 29, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release third quarter 2014 financial results on Thursday, November 6,...
Raptor Pharmaceutical Announces Management Changes
October 23, 2014 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has strengthened its leadership team with the hiring of two new executives: David...
Raptor Pharmaceutical to Present at Leerink Rare Disease Roundtable
September 23, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Leerink Rare Disease Roundtable in New York on...
Raptor Pharmaceutical to Present at Upcoming Investor Conference in September
August 27, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 27, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Morgan Stanley Global Healthcare Conference in...
Raptor Pharmaceutical Reports Second Quarter 2014 Financial Results and Provides Corporate Update
August 07, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Global net product sales for PROCYSBI® of $16.3 million reported for second quarter 2014
Raising net sales guidance for PROCYSBI to $65 to $70 million for 2014
Company to host...